The glycoprotein V of the blood platelets is an important switch point for haemostasis and thrombus formation. This new finding could have great clinical potential. When our blood vessels are injured ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video at the ASH Annual Meeting and Exposition, Sriram M. Krishnaswamy, PhD, of the University ...

There has been increasing interest in the potential roles of an activated coagulation system in the biology of solid tumors, and in the effects of antithrombotic agents such as the ...

Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists have now identified a mechanism they believe to be implicated. A particular protein triggers a part of our ...

During the past two decades, there has been significant progress in the development of new medications for treatment and prevention of thrombotic complications. With the introduction of new ...

Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be ...

Idarucizumab, which was granted Breakthrough Therapy Designation by the FDA, was shown to restore the blood clotting mechanism in healthy volunteers1,2 This is the first time that such an effect was ...

To understand the pharmacology and mechanism of action of ximelagatran, a review of the formation and function of thrombin is warranted. [10] The generation of thrombin is limited under normal ...

When our blood vessels are injured by cuts, abrasions, or bruises, it is vital that the bleeding is stopped, and the wound is sealed. This process is called hemostasis and involves two main components ...